Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
| Series: | Neural Regeneration Research |
| Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2018;volume=13;issue=2;spage=224;epage=225;aulast=Souchet |